​Innovation Opportunities in Biotech with Mr. Chandra Ramanathan

​Date: April 2nd, 2025
Time: 5:30pm-6:30pm IST

​​Join us for an exclusive session with Mr. Chandra Ramanathan, a biopharmaceutical executive with extensive experience translating scientific ideas into treatment options and access for patients with high medical needs.

​This interactive session is bound to be impactful to participants envisioning startups in life sciences. This session is hosted in association with Nucleate India (Emerging Chapter).

​FutureX Brief

​Google Cloud India and Campus Fund are excited to announce the launch of FutureX, a national platform designed to identify ground-breaking innovation and nurture India's most promising student-led startups in frontier technologies.

​About Nucleate

​Nucleate is a nonprofit dedicated to empowering tomorrow’s biotech leaders by educating today’s academic trainees. With 28 chapters across 150+ academic institutions worldwide and 1000+ student leaders, Nucleate’s equity-free Activator program supports startups tackling health and sustainability challenges. To date, Nucleate has helped form 300+ startup teams, raising over $320M for breakthroughs in protein sequencing, drug design, synthetic biology, and biomanufacturing.

​About the Speaker

​Chandra is currently the Head of External Innovation, Life Sciences Innovation Group at Danaher Corporation. He is focusing on technologies with potential to transform drug discovery and development – increasing clinical translation success and bringing innovative options quicker to patients.

​Previously, Chandra held various leadership positions over twelve years at Bayer. Most recently, he was the Global Head of Pharma R&D Open Innovation at Bayer, where he led the Open Innovation Centers (OICs) around the world (US, Europe, Japan, China, and Singapore). Key accomplishments include the establishment of an innovation center and approval of a Cell & Gene Therapy Incubator in Cambridge, MA (Investment value: $200+ Million).

​Chandra is an adjunct assistant professor at the Tufts School of Medicine. He is on the MassBIO Board, serving as the Chair of their Innovation subcommittee. He is also an Innovation, Development & Entrepreneurial Advisory Board Member at the Johns Hopkins University and Board of Trustees at McLean Hospital.